Lili Xiao

Guangzhou, 511436, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Enhanced Structure Ductility and Sodium Storage Kinetics of High-Capacity Sulfide Anodes via Medium-Entropy Engineering.

Enhanced Structure Ductility and Sodium Storage Kinetics of High-Capacity Sulfide Anodes via Medium-Entropy Engineering.

Journal: Small methods

Published: January 13, 2026

Associations of Fecal Microplastics with Oxidative Damage and Cardiopulmonary Function: Evidence from a Pilot Study.

Associations of Fecal Microplastics with Oxidative Damage and Cardiopulmonary Function: Evidence from a Pilot Study.

Journal: Toxics

Published: December 19, 2025

Exposure to personal care products and thyroid function in adults: Unveiling the association and potential mechanism.

Exposure to personal care products and thyroid function in adults: Unveiling the association and potential mechanism.

Journal: Ecotoxicology and environmental safety

Published: October 31, 2025

SENP2 negatively regulates RIG-I/MDA5 mediated innate immunity in black carp.

SENP2 negatively regulates RIG-I/MDA5 mediated innate immunity in black carp.

Journal: Fish & shellfish immunology

Published: October 25, 2024

Efficacy and Safety of Apatinib Plus Vinorelbine in Patients With Wild-Type Advanced Non-Small Cell Lung Cancer After Second-Line Treatment Failure: A Nonrandomized Clinical Trial.

Efficacy and Safety of Apatinib Plus Vinorelbine in Patients With Wild-Type Advanced Non-Small Cell Lung Cancer After Second-Line Treatment Failure: A Nonrandomized Clinical Trial.

Journal: JAMA network open

Published: March 20, 2020

Detection of Nonreciprocal/Reciprocal ALK Translocation as Poor Predictive Marker in Patients With First-Line Crizotinib-Treated ALK-Rearranged NSCLC.

Detection of Nonreciprocal/Reciprocal ALK Translocation as Poor Predictive Marker in Patients With First-Line Crizotinib-Treated ALK-Rearranged NSCLC.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: July 21, 2019

Investigation of efficacy and acquired resistance for EGFR-TKI plus bevacizumab as first-line treatment in patients with EGFR sensitive mutant non-small cell lung cancer in a Real world population.

Investigation of efficacy and acquired resistance for EGFR-TKI plus bevacizumab as first-line treatment in patients with EGFR sensitive mutant non-small cell lung cancer in a Real world population.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: July 14, 2019

Tyrosine kinase inhibitor acquired resistance mechanism alternates between EGFR and ALK in a lung adenocarcinoma patient.

Tyrosine kinase inhibitor acquired resistance mechanism alternates between EGFR and ALK in a lung adenocarcinoma patient.

Journal: Thoracic cancer

Published: December 13, 2018

Crizotinib presented with promising efficacy but for concomitant mutation in next-generation sequencing-identified ROS1-rearranged non-small-cell lung cancer.

Crizotinib presented with promising efficacy but for concomitant mutation in next-generation sequencing-identified ROS1-rearranged non-small-cell lung cancer.

Journal: OncoTargets and therapy

Published: November 10, 2018

Showing 1-9 of 9

Last Updated: 09/26/2026